OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-14.36%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$203M
AUM Growth
+$203M
(-19%)
Cap. Flow
-$16.4M
Cap. Flow
% of AUM
-8.05%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
56
New
10
Increased
13
Reduced
13
Closed
7
Top Buys
| 1 |
Indaptus Therapeutics
INDP
|
$3.53M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$2.77M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.63M |
| 4 |
TG Therapeutics
TGTX
|
$2.62M |
| 5 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$2.27M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$8.94M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$7.91M |
| 3 |
MiMedx Group
MDXG
|
$7.15M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
$4.97M |
| 5 |
CEMP
Cempra, Inc.
CEMP
|
$3.62M |
Sector Composition
| 1 | Healthcare | 80.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MacroGenics
MGNX
$112M
| – | – | -90,000 | Closed | -$3.42M |
|
|
CLVS
52
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | -90,000 | Closed | -$7.91M |
|